Please enable JS

ARTICLES & TESTIMONIALS

FILTER BY TYPE

Most Recent

Categories

ARCHIVES

Kat MacFarlane interview with Talk 107.3 Baton Rouge

May 05/50SN Staff/ Advocates in the news

Louisiana advocate Kat MacFarlane speak about the importance of physician/patient relationships, the promise of biosimilars when made available transparently, and why she is testifying about biosimilar substitution in the legislature.

READ MORE

KODL interview on biosimilars

May 04/50SN Staff/ Advocates in the news

Oregon Advocate Anna Meyer speaks on an interview for KODL for Biosimilars

READ MORE

HEALTH CENTRAL – Biologics and Substitution: Advocating for Your Right to Know

Apr 29/50SN Staff/ Advocates in the news GHLF in the news

Would you want your pharmacist to tell you and your doctor if they substituted your biologic medication with a similar, but not identical drug? Of course you would. But as biosimilars — a less expensive mimic of Biologics — are introduced on the U.S. market, individual states are deciding how and when they can be […]

READ MORE

GHLF Asks Patients: “How Does It Feel to be Switched?”

Apr 20/50SN Staff/ Press Releases

GHLF released the findings of a national survey of stabilized patients that explored their perspectives on switching prescribed biological medicines. The survey, “Patient Perspectives on Medication Switching for Non- Medical Reasons,” found 98 percent of the 177 eligible respondents said insurance companies and pharmacists should not switch effective therapies without patient and physician notification.

READ MORE

Letter to FDA on naming

Apr 09/50SN Staff/ Letters and Testimony

The clock starts ticking as soon as a patient experiences symptoms of an adverse reaction. When the worst happens, we want our healthcare team to have the maximum information available to them in order to find the cause quickly and accurately. That is why the Global Healthy Living Foundation (GHLF) and its members fully support the FDA’s decision to incorporate a distinguishable name for the first approved biosimilar – filgrasim-sndz. There has been a lot of debate about […]

READ MORE